Eikon Therapeutics to Participate in November Investor Conferences
Eikon Therapeutics CEO Roger M. Perlmutt is scheduled to participate in multiple investor conferences in November.
Eikon Therapeutics CEO Roger M. Perlmutt is scheduled to participate in multiple investor conferences in November.